Sociodemographic Predictors of Prostate Cancer Risk Category at Diagnosis: Unique Patterns of Significant and Insignificant Disease

Journal of Urology

Volumn 181, Issue 4, 2009, Pages 1622-1627

  Dall'Era, Marc A ^a   Hosang, Nap ^c   Konety, Badrinath ^a   Cowan, Janet E ^a   Carroll, Peter R ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

continental population groups; insurance; major medical; prostate; prostatic neoplasms; social class

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ASIAN; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER STAGING; DEMOGRAPHY; EDUCATIONAL STATUS; HISPANIC; HUMAN; HUMAN TISSUE; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICARE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE; RETROSPECTIVE STUDY; SOCIAL STATUS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 62049084009     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.11.123     Document Type: Article

References (17)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Cooperberg M.R., Lubeck D.P., Mehta S.S., and Carroll P.R. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol 170 (2003) S21
3. Master V.A., Chi T., Simko J.P., Weinberg V., and Carroll P.R. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol 174 (2005) 1789
4. Etzioni R., Penson D.F., Legler J.M., di Tommaso D., Boer R., Gann P.H., et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94 (2002) 981
5. Harlan S.R., Cooperberg M.R., Elkin E.P., Lubeck D.P., Meng M.V., Mehta S.S., et al. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol 170 (2003) 1804
6. Grossfeld G.D., Latini D.M., Downs T., Lubeck D.P., Mehta S.S., and Carroll P.R. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol 168 (2002) 2510
7. Robbins A.S., Koppie T.M., Gomez S.L., Parikh-Patel A., and Mills P.K. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer 110 (2007) 1255
8. Lubeck D.P., Litwin M.S., Henning J.M., Stier D.M., Mazonson P., Fisk R., et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 48 (1996) 773
9. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969
10. Bastian P.J., Mangold L.A., Epstein J.I., and Partin A.W. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer 101 (2004) 2001
11. Cooperberg M.R., Broering J.M., Litwin M.S., Lubeck D.P., Mehta S.S., Henning J.M., et al. The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol 171 (2004) 1393
12. Bouchardy C., Verkooijen H.M., and Fioretta G. Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer 119 (2006) 1145
13. MacKinnon J.A., Duncan R.C., Huang Y., Lee D.J., Fleming L.E., Voti L., et al. Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures. Cancer Epidemiol Biomarkers Prev 16 (2007) 756
14. Mariotto A.B., Etzioni R., Krapcho M., and Feuer E.J. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer 109 (2007) 1877
15. Underwood III W., Wei J., Rubin M.A., Montie J.E., Resh J., and Sanda M.G. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol 22 (2004) 20
16. Ward E., Halpern M., Schrag N., Cokkinides V., DeSantis C., Bandi P., et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58 (2008) 9
17. Carter H.B., Kettermann A., Warlick C., Metter E.J., Landis P., Walsh P.C., et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 178 (2007) 2359